Induction of replication in human corneal endothelial cells by E2F2 transcription factor cDNA transfer

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 10, 2005, Pages 3597-3603

  McAlister, James C ^a,b   Joyce, Nancy C ^b   Harris, Desbea L ^b   Ali, Robin R ^a   Larkin, Daniel F P ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR E2F2; E2F2 PROTEIN, HUMAN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL DENSITY; CONFOCAL MICROSCOPY; CORNEA ENDOTHELIUM; DNA TRANSFER; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NICK END LABELING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPECULAR MICROSCOPY; VIRUS REPLICATION; CELL COUNT; CELL CULTURE; CELL DIVISION; CYTOLOGY; DNA REPLICATION; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN ADENOVIRUS; METABOLISM; PHYSIOLOGY;

ADENOVIRUSES, HUMAN; APOPTOSIS; CELL COUNT; CELL DIVISION; CELLS, CULTURED; DNA REPLICATION; DNA, COMPLEMENTARY; E2F2 TRANSCRIPTION FACTOR; ENDOTHELIUM, CORNEAL; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IN SITU NICK-END LABELING; MICROSCOPY, CONFOCAL; TRANSFECTION;

EID: 32944473806     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0551     Document Type: Article

References (34)

1. Dikstein S, Maurice DM. The metabolic basis to the fluid pump in the cornea. J Physiol. 1972;221:29-41.
2. Van Horn DL, Sendele DD, Seideman S, Buco PJ. Regenerative capacity of the corneal endothelium in rabbit and cat. Invest Ophthalmol Vis Sci. 1977;16:597-613.
3. Tuft SJ, Williams KA, Coster DJ. Endothelial repair in the rat cornea. Invest Opbthalmol Vis Sci. 1986;27:1199-1204.
4. Laule A, Cable MK, Hoffman CE, Hanna C. Endothelial cell population changes of human cornea during life. Arch Ophthalmol. 1978;96:2031-2025.
5. Ing JJ, Ing HH, Nelson LR, et al. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998;105:1855-1865.
6. Armitage WJ, Easty DL. Factors influencing the suitability of organ-cultured corneas for transplantation. Invest Ophthalmol Vis Sci. 1997;38:16-24.
7. Waring GO, III, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium: normal and pathologic structure and function. Ophthalmology. 1982;89:531-590.
8. Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA. Corneal transplantation in the United Kingdom and Republic of Ireland. Br J Ophthalmol. 1993;77:650-656.
9. Borderie VM, Touzeau O, Allouch C, et al. The results of successful penetrating keratoplasty using donor organ-cultured corneal tissue. Transplantation. 1999;67:1433-1438.
10. La Thangue NB. The yin and yang of E2F-1: balancing life and death. Nat Cell Biol. 2003;5:655-660.
11. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001;414:457-462.
12. Joyce NC, Meklir B, Joyce SJ, Zieske J. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci. 1996;37:645-655.
13. Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37:1566-1575.
14. Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000;41:660-667.
15. Zhu CC, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci. 2004;45:1743-1751.
16. Joyce NC, Zhu CC. Human corneal endothelial cell proliferation: potential for use in regenerative medicine. Cornea. 2004;23(suppl 1):S8-S19.
17. Brown VD, Gallie BL. The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation. Mol Cell Biol. 2002;22:1390-1401.
18. Feldman ST, Gjerset R, Gately D, Chien KR, Feramisco JR. Expression of SV40 virus large T antigen by recombinant adenoviruses activates proliferation of corneal endothelium in vitro. J Clin Invest. 1993;91:1713-1720.
19. Wilson SE, Weng J, Blair S, et al. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36:32-40.
20. Smith DS, Leone G, DeGregori J, Ahmed MN, Qumsiyeh MB, Nevins JR. Induction of DNA replication in adult rat neurons by deregulation of the retinoblastoma/E2F G1 cell cycle pathway. Cell Growth & Differ. 2000;11:625-633.
21. Chen Q, Hung FC, Fromm L, Overbeek PA. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2. Invest Opbthalmol Vis Sci. 2000;41:4223-4231.
22. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA. 1997;94:7245-7250.
23. Joyce NC, Harris DL, McAlister JC, Ali RR, Larkin DFP. Over-expression of the transcription factor E2F2 induces cell cycle progression in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 2004;45:1340-1348.
24. Larkin DFP, Oral HB, Ring CJA, Lemoine NR, George AJT. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation. 1996;61:363-370.
25. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Olif A, Heimbrook DC. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol. 1993;13:7802-7812.
26. Brideau AD, Banfield BW, Enquist LW. The Us9 gene product of pseudorabies virus, an alpha herpes virus, is a phosphorylated, tail-anchored type II membrane protein. J. Virol. 1998;72:4560-4570.
27. Kalejta RF, Brideau AD, Banfield BW, Beavis AJ. An integral membrane green fluorescent protein marker, Us9-GFP, is quantitatively retained in cells during propidium iodide-based cell cycle analysis by flow cytometry. Exp Cell Res. 1999;248:322-328.
28. Joyce NC, Matkin ED, Neufeld AH. Corneal endothelial wound closure in vitro: effects of EGF and/or indomethacin. Invest Ophthalmol Vis Sci. 1989;30:1548-1559.
29. Magae J, Wu CL, Illenye S, Harlow E, Heintz NH. Nuclear localization of DP and E2F transcription factors by heterodimeric partner retinoblastoma protein family members. J Cell Sci. 1996;109:1717-1726.
30. Oral HB, Larkin DFP, Fehervari Z, et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther. 1998;12:273-277.
31. Rayner SA, Larkin DFP, George AJT. TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest Ophthalmol Vis Sci. 2001;42:1568-1573.
32. Dolbeare F. Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part III. Proliferation in normal, injured and diseased tissue, growth factors, differentiation, DNA replication sites and in situ hybridization. Histochem J. 1996;28:531-575.
33. Gonzalez-Beltran F, Morales-Ramirez P. In vivo repair during G1 of DNA lesions eliciting sister chromatid exchanges induced by methylnitrosourea or ethylnitrosourea in BrdU substituted or unsubstituted DNA in murine salivary gland cells. Mutat Res. 1999;425:239-247.
34. Rahi AH, Robins E. Human corneal endothelial cell repair in health and disease. Trans Ophthalmol Soc UK. 1981;101:30-34.